Get started

ENDP

ENDP - 26 year all time low ENDO has $10B assets, $1.4B cash, $3B sales. In Q1 2022, revenue was $654M alone. It’s trading at a severely undervalued market cap of $141M. This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives. ENDO just won an 8 year opioid lawsuit case Friday, July 1st. Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals. Their pipeline includes 50+ other OTC medications.
ELong
by Irishmin31
Endo International Bullish News | Upside PotentialEndo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules. According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30, 2020. (Source: prnewswire.com) Endo International plc (NASDAQ: ENDP) announced that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (NASDAQ: RDUS) to register, commercialize and distribute abaloparatide on an exclusive basis in Canada. (Source: newswire.ca) "We are very pleased to work with Radius to possibly bring a new treatment option to the market for Canadian osteoporosis patients," said Livio Di Francesco, Vice President and General Manager of Paladin. Please leave me a message if you want to test the buy and sell indicators that i am using.
ELong
by BuySellMarketMaker
ENDP, ($3.28) Aroon Indicator entered an Uptrend Over the last three days, A.I.dvisor has detected that ENDP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. A.I.dvisor backtested this indicator and found 187 similar cases, 159 of which were successful. Based on this data, the odds of success are 85%. Current price $3.26 is below $3.36 the lowest resistance line found by A.I. Throughout the month of 08/25/20 - 09/25/20, the price experienced a +15% Uptrend. During the week of 09/18/20 - 09/25/20, the stock enjoyed a +0.46% Uptrend growth. Bullish Trend Analysis The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ENDP's RSI Oscillator exited the oversold zone, Tickeron A.I. shows that 34 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%. The Momentum Indicator moved above the 0 level on September 15, 2020. You may want to consider a long position or call options on ENDP as a result. Tickeron A.I. detected that in 64 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%. The Moving Average Convergence Divergence (MACD) for ENDP just turned positive on September 11, 2020. Looking at past instances where ENDP's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%. ENDP moved above its 50-day Moving Average on September 25, 2020 date and that indicates a change from a downward trend to an upward trend. Following a +3.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENDP advanced for three days, in 220 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
ELong
by AlTorress
ENDP - DAILY CHART Hi, today we are going to talk about Endo International and its current landscape. Endo International is poised to receive increasing attention from the market as relevant events are taking place. The Irish-domiciled generics and specialty branded pharmaceutical company has been involved in the US lawsuits against opioid makers this year and has exposure to ongoing developments in these cases and could diminish attempt to rebound. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
E
by Igor-Silva
ENDP - Possible Momentum Change. RSI Bulls FOUNDEndo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland. P/E Current -0.49 P/E Ratio (with extraordinary items) -0.87 SHORT INTEREST 28.76M 07/31/19 Average Recommendation: HOLD Average Target Price: 5.48
ELong
by DEXWireNews
ENDP - BREAKOUT PRONE - UPDATEENDP has been consolidating from it's impressive rally in the beginning of the year. ENDP has shown strong support at it's 52 Week high. It hasn't even retraced .236 of the rally. This leads me to believe we are going to have an extended primary Wave 1. How can we discover that wave 1 was extending? Suppose the minor wave 3 travels more than 161.8% of minor wave 1 then we are seeing an extending wave 1. Suppose wave 3 is of normal proportion. Once the minor wave 4 is finished, you should draw a channel where the lower line connects the bottom of minor wave 2 and minor wave 4. The upper parallel line should be made to touch the top of minor wave 3. If the minor wave 5 goes above the top of this channel, then we are seeing the minor wave 5 within wave 1 extending, which means the whole wave 1 is an extending wave. Extended 3rd Wave: WEEKLY: DAILY: 1HR:
ELong
by FibMarketWatch